CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
intermittent theta burst stimulation (iTBS) or sham stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04832750
NCT04832750N/ACompleted

Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep

University of Oldenburg·observational·Posted Apr 6, 2021·Updated Dec 11, 2024

In Brief

An observational study evaluating intermittent theta burst stimulation (iTBS) or sham stimulation for Major Depressive Episode and 2 related conditions. Completed, enrolled 102 participants across 1 site.

Detailed Summary

Advances in repetitive transcranial magnetic stimulation (rTMS) protocols with intermittent theta-burst stimulation (iTBS) have significantly decreased the duration for one single session and thereby enabled accelerated treatment plans with multiple sessions per day, potentially reducing the total treatment duration. This randomized, placebo-controlled study investigates the effects of accelerated iTBS treatment with connectivity-informed neuronavigation on symptom severity, sleep, interoception, and cognitive control in patients with major depressive disorder and with or without comorbid borderline personality disorder using magnetic resonance imaging (MRI).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 6, 2021
Enrollment StartMay 3, 2021
Primary CompletionJun 14, 2024
Study CompletionJul 26, 2024
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 5.2 years ago

Interventions

intermittent theta burst stimulation (iTBS) or sham stimulationdevice

30 sessions of iTBS over 2 weeks (3 sessions per day, 5 days per week)